Read + Share
Amedeo Smart
Independent Medical Education
Kitagawa S, Zenke Y, Taki T, Aokage K, et al. Prognostic value of predominant subtype in pathological stage II-III lung adenocarcinoma with epidermal growth factor receptor mutation. Lung Cancer 2024;188:107453.PMID: 38160515
Email
LinkedIn
Facebook
Twitter
Privacy Policy